ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Nexalin Technologies Inc

Nexalin Technologies Inc (NXL)

3,82
-0,08
(-2,05%)
Fermé 23 Novembre 10:00PM
3,82
0,00
( 0,00% )
Avant marché: 12:38PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
3,82
Prix Achat
3,58
Prix Vente
3,90
Volume échangé
15
0,00 Fourchette du Jour 0,00
0,2528 Plage de 52 semaines 4,36
Cap du marché
Clôture Veille
3,82
Ouverture
-
Dernière Transaction
2
@
3.82
Dernière heure de transaction
12:00:18
Volume financier
-
VWAP
-
Volume moyen (3 m)
1 667 916
Actions en circulation
12 861 605
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-10,57
Bénéfice par action (BPA)
-0,36
Chiffre d'affairess
111k
Bénéfice net
-4,65M

À propos de Nexalin Technologies Inc

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Nexalin Technologies Inc est coté dans le secteur Electromedical Apparatus de la NASDAQ avec le ticker NXL. Le dernier cours de clôture d'Nexalin Technologies était de US$3,82. Au cours de la dernière année, les actions de Nexalin Technologies ont été négociées dans une fourchette de prix de US$ 0,2528 à US$ 4,36.

Nexalin Technologies compte actuellement 12 861 605 actions en circulation. La capitalisation boursière d'Nexalin Technologies est de US$49,13 million. Nexalin Technologies a un ratio cours/bénéfice (ratio PE) de -10.57.

NXL Dernières nouvelles

Nexalin Technology CEO Provides Letter to Shareholders

HOUSTON, TX, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today released a letter to shareholders from its CEO Mark White: Dear...

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on November 5, 2024, at 4:15...

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market...

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

HOUSTON, TX, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced publication of a landmark study titled, “Altered...

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous Clinical Trial Treating Veterans with Mild Traumatic...

New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients

HOUSTON, TX, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced results from a clinical trial demonstrating improvements...

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

HOUSTON, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announces the appointment of Carolyn Shelton as Senior Vice President of...

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

HOUSTON, TX, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) announced its participation in a high-profile Congressional roundtable...

Veritone and Nuix Combine AI Expertise to Offer Turn-Key Solutions for Growing Volumes of Video and Audio Data

Veritone integrates its extensive AI-enabled redaction capabilities into Nuix’s NEO Platform and ecosystem to optimize audio and visual workflows Veritone, Inc. (NASDAQ: VERI), a leader in...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.28-6.829268292684.14.33.58474413.93069129CS
41.351.58730158732.524.362.068927216582.8518783CS
122.8895310.5319720580.93054.360.59116679162.42263139CS
262.62218.3333333331.24.360.5321123082.06026961CS
523.4543944.5720535960.36574.360.252812897341.9494528CS
1561.1241.48148148152.74.360.25286462741.895454CS
2601.1241.48148148152.74.360.25286462741.895454CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
QMMMQMMM Holdings Limited
US$ 1,29
(72,02%)
13,77M
ANLAdlai Nortye Ltd
US$ 3,90
(48,29%)
13
WLDSWearable Devices Ltd
US$ 2,70
(43,62%)
2,33M
RGTIRigetti Computing Inc
US$ 2,49
(43,10%)
27,53M
QMCOQuantum Corporation
US$ 11,98
(31,22%)
942,21k
ONCTOncternal Therapeutics Inc
US$ 0,7429
(-34,83%)
28,19k
AKTSAkoustis Technologies Inc
US$ 0,0683
(-32,11%)
4,86M
HSTMHealthStream Inc
US$ 25,12
(-21,96%)
6
ACTUActuate Therapeutics Inc
US$ 7,11
(-20,82%)
1
WSBCPWesBanco Inc
US$ 20,01
(-20,72%)
4
RGTIRigetti Computing Inc
US$ 2,49
(43,10%)
27,53M
QMMMQMMM Holdings Limited
US$ 1,27
(69,36%)
13,77M
ELABElevai Labs Inc
US$ 0,0171
(-14,93%)
10,28M
AKTSAkoustis Technologies Inc
US$ 0,0683
(-32,11%)
4,86M
QUBTQuantum Computing Inc
US$ 6,88
(12,79%)
4,21M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock